Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin

Journal of Immunology

Volumn 184, Issue 12, 2010, Pages 7108-7115

  Cruse, Glenn ^a,b   Fernandes, Vitor E ^a   De Salort, Jose ^a   Pankhania, Depesh ^a   Marinas, Marta S ^a   Brewin, Hannah ^a   Andrew, Peter W ^a   Bradding, Peter ^a   Kadioglu, Aras ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; LEUKOTRIENE C4; PNEUMOLYSIN; BACTERIAL PROTEIN; PLY PROTEIN, STREPTOCOCCUS PNEUMONIAE; STREPTOLYSIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL SURVIVAL; CELL VIABILITY; CELLULAR IMMUNITY; COCULTURE; CYTOKINE PRODUCTION; CYTOTOXICITY; HISTAMINE RELEASE; HUMAN; HUMAN CELL CULTURE; IMMUNOSTIMULATION; LUNG ALVEOLUS CELL; LUNG INFECTION; MAST CELL; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA; CELL CULTURE; CYTOLOGY; DEGRANULATION; IMMUNOLOGY; LUNG; MICROBIOLOGY; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; CELL DEGRANULATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; LUNG; MAST CELLS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; STREPTOLYSINS;

EID: 77953629095     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900802     Document Type: Article

References (56)

1. Bradding, P., A. F. Walls, and S. T. Holgate. 2006. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 117: 1277-1284.
2. Brown, J. M., T. M. Wilson, and D. D. Metcalfe. 2008. The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 38: 4-18.
3. Bradding, P., and G. Cruse. 2008. Mast cells: Biological properties and role in health and allergic diseases. In Allergy and Allergic Diseases, 2nd Ed. A. B. Kay, A. P. Kaplan, J. Bousquet, and P. Holt, eds. Wiley-Blackwell, Chichester, U.K, p. 217-257.
4. Bischoff, S. C., and S. Krämer. 2007. Human mast cells, bacteria, and intestinal immunity. Immunol. Rev. 217: 329-337.
5. Mekori, Y. A., and D. D. Metcalfe. 2000. Mast cells in innate immunity. Immunol. Rev. 173: 131-140.
6. Metcalfe, D. D., D. Baram, and Y. A. Mekori. 1997. Mast cells. Physiol. Rev. 77: 1033-1079.
7. Echtenacher, B., D. N. Männel, and L. Hültner. 1996. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381: 75-77. (Pubitemid 26130005)
8. Malaviya, R., T. Ikeda, E. Ross, and S. N. Abraham. 1996. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381: 77-80.
9. Supajatura, V., H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167: 2250-2256. (Pubitemid 32747537)
10. Jippo, T., E. Morii, A. Ito, and Y. Kitamura. 2003. Effect of anatomical distribution of mast cells on their defense function against bacterial infections: demonstration using partially mast cell-deficient tg/tg mice. J. Exp. Med. 197: 1417-1425.
11. von Köckritz-Blickwede, M., O. Goldmann, P. Thulin, K. Heinemann, A. Norrby-Teglund, M. Rohde, and E. Medina. 2008. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111: 3070-3080.
12. Di Nardo, A., A. Vitiello, and R. L. Gallo. 2003. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170: 2274-2278.
13. Féger, F., S. Varadaradjalou, Z. Gao, S. N. Abraham, and M. Arock. 2002. The role of mast cells in host defense and their subversion by bacterial pathogens. Trends Immunol. 23: 151-158. (Pubitemid 34178298)
14. Malaviya, R., E. A. Ross, J. I. MacGregor, T. Ikeda, J. R. Little, B. A. Jakschik, and S. N. Abraham. 1994. Mast cell phagocytosis of FimH-expressing enterobacteria. J. Immunol. 152: 1907-1914.
15. Balakrishnan, I., P. Crook, R. Morris, and S. H. Gillespie. 2000. Early predictors of mortality in pneumococcal bacteraemia. J. Infect. 40: 256-261.
16. Lim, W. S., J. T. Macfarlane, T. C. Boswell, T. G. Harrison, D. Rose, M. Leinonen, and P. Saikku. 2001. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 56: 296-301.
17. Denny, F. W., and F. A. Loda. 1986. Acute respiratory infections are the leading cause of death in children in developing countries. Am. J. Trop. Med. Hyg. 35: 1-2.
18. Berkley, J. A., B. S. Lowe, I. Mwangi, T. Williams, E. Bauni, S. Mwarumba, C. Ngetsa, M. P. Slack, S. Njenga, C. A. Hart, et al. 2005. Bacteremia among children admitted to a rural hospital in Kenya. N. Engl. J. Med. 352: 39-47.
19. Kadioglu, A., J. N. Weiser, J. C. Paton, and P. W. Andrew. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6: 288-301.
20. Mitchell, T. J., P. W. Andrew, F. K. Saunders, A. N. Smith, and G. J. Boulnois. 1991. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol. Microbiol. 5: 1883-1888.
21. Cockeran, R., H. C. Steel, T. J. Mitchell, C. Feldman, and R. Anderson. 2001. Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils. Infect. Immun. 69: 3494-3496.
22. Cockeran, R., A. J. Theron, H. C. Steel, N. M. Matlola, T. J. Mitchell, C. Feldman, and R. Anderson. 2001. Proinflammatory interactions of pneumolysin with human neutrophils. J. Infect. Dis. 183: 604-611.
23. Johnson, M. K., D. Boese-Marrazzo, and W. A. Pierce, Jr. 1981. Effects of pneumolysin on human polymorphonuclear leukocytes and platelets. Infect. Immun. 34: 171-176.
24. Kadioglu, A., W. Coward, M. J. Colston, C. R. Hewitt, and P. W. Andrew. 2004. CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection. Infect. Immun. 72: 2689-2697.
25. Braun, J. S., R. Novak, G. Gao, P. J. Murray, and J. L. Shenep. 1999. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect. Immun. 67: 3750-3756.
26. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes. Infect. Immun. 62: 1501-1503.
27. Berry, A. M., J. Yother, D. E. Briles, D. Hansman, and J. C. Paton. 1989. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae. Infect. Immun. 57: 2037-2042.
28. Canvin, J. R., A. P. Marvin, M. Sivakumaran, J. C. Paton, G. J. Boulnois, P. W. Andrew, and T. J. Mitchell. 1995. The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus. J. Infect. Dis. 172: 119-123.
29. Kadioglu, A., N. A. Gingles, K. Grattan, A. Kerr, T. J. Mitchell, and P. W. Andrew. 2000. Host cellular immune response to pneumococcal lung infection in mice. Infect. Immun. 68: 492-501.
30. Kadioglu, A., S. Taylor, F. Iannelli, G. Pozzi, T. J. Mitchell, and P. W. Andrew. 2002. Upper and lower respiratory tract infection by Streptococcus pneumoniae is affected by pneumolysin deficiency and differences in capsule type. Infect. Immun. 70: 2886-2890.
31. Feldman, C., N. C. Munro, P. K. Jeffery, T. J. Mitchell, P. W. Andrew, G. J. Boulnois, D. Guerreiro, J. A. Rohde, H. C. Todd, P. J. Cole, et al. 1991. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo. Am. J. Respir. Cell Mol. Biol. 5: 416-423.
32. Kerr, A. R., J. J. Irvine, J. J. Search, N. A. Gingles, A. Kadioglu, P. W. Andrew, W. L. McPheat, C. G. Booth, and T. J. Mitchell. 2002. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun. 70: 1547-1557.
33. Sanmugalingham, D., E. De Vries, R. Gauntlett, F. A. Symon, P. Bradding, and A. J. Wardlaw. 2000. Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cells. Clin. Exp. Allergy 30: 255-263.
34. Butterfield, J. H., D. A. Weiler, L. W. Hunt, S. R. Wynn, and P. C. Roche. 1990. Purification of tryptase from a human mast cell line. J. Leukoc. Biol. 47: 409-419.
35. Kirshenbaum, A. S., C. Akin, Y. Wu, M. Rottem, J. P. Goff, M. A. Beaven, V. K. Rao, and D. D. Metcalfe. 2003. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk. Res. 27: 677-682.
36. Bättig, P., and K. Mühlemann. 2008. Influence of the spxB gene on competence in Streptococcus pneumoniae. J. Bacteriol. 190: 1184-1189. (Pubitemid 351217035)
37. Kulka, M., L. Alexopoulou, R. A. Flavell, and D. D. Metcalfe. 2004. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114: 174-182.
38. Malaviya, R., and S. N. Abraham. 2000. Role of mast cell leukotrienes in neutrophil recruitment and bacterial clearance in infectious peritonitis. J. Leukoc. Biol. 67: 841-846.
39. Arock, M., E. Ross, R. Lai-Kuen, G. Averlant, Z. Gao, and S. N. Abraham. 1998. Phagocytic and tumor necrosis factor alpha response of human mast cells following exposure to gram-negative and gram-positive bacteria. Infect. Immun. 66: 6030-6034.
40. Kalin, M., K. Kanclerski, M. Granström, and R. Möllby. 1987. Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin). J. Clin. Microbiol. 25: 226-229. (Pubitemid 17232408)
41. Malley, R., P. Henneke, S. C. Morse, M. J. Cieslewicz, M. Lipsitch, C. M. Thompson, E. Kurt-Jones, J. C. Paton, M. R. Wessels, and D. T. Golenbock. 2003. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl. Acad. Sci. USA 100: 1966-1971.
42. Varadaradjalou, S., F. Féger, N. Thieblemont, N. B. Hamouda, J. M. Pleau, M. Dy, and M. Arock. 2003. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33: 899-906.
43. Okumura, S., J. Kashiwakura, H. Tomita, K. Matsumoto, T. Nakajima, H. Saito, and Y. Okayama. 2003. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 102: 2547-2554. (Pubitemid 37193594)
44. Theoharides, T. C., D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros. 2007. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol. Rev. 217: 65-78.
45. McCurdy, J. D., T. J. Olynych, L. H. Maher, and J. S. Marshall. 2003. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170: 1625-1629.
46. Sur, R., J. Hall, D. Cavender, and R. Malaviya. 2009. Role of Janus kinase-2 in IgE receptor-mediated leukotriene C4 production by mast cells. Biochem. Biophys. Res. Commun. 390: 786-790.
47. Okugawa, S., Y. Ota, T. Kitazawa, K. Nakayama, S. Yanagimoto, K. Tsukada, M. Kawada, and S. Kimura. 2003. Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. Am. J. Physiol. Cell Physiol. 285: C399-C408.
48. Barbuti, G., M. Moschioni, S. Censini, A. Covacci, C. Montecucco, and P. Montemurro. 2006. Streptococcus pneumoniae induces mast cell degranulation. Int. J. Med. Microbiol. 296: 325-329.
49. Mizgerd, J. P. 2002. Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs. Semin. Immunol. 14: 123-132.
50. Kadioglu, A., and P. W. Andrew. 2004. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 25: 143-149.
51. Beiter, K., F. Wartha, B. Albiger, S. Normark, A. Zychlinsky, and B. Henriques-Normark. 2006. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16: 401-407.
52. Marks, M., T. Burns, M. Abadi, B. Seyoum, J. Thornton, E. Tuomanen, and L. A. Pirofski. 2007. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Infect. Immun. 75: 1586-1597.
53. Ramanathan, B., E. G. Davis, C. R. Ross, and F. Blecha. 2002. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 4: 361-372. (Pubitemid 34293642)
54. Molhoek, E. M., A. L. den Hertog, A. M. de Vries, K. Nazmi, E. C. Veerman, F. C. Hartgers, M. Yazdanbakhsh, F. J. Bikker, and D. van der Kleij. 2009. Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol. Chem. 390: 295-303.
55. Malaviya, R., Z. Gao, K. Thankavel, P. A. van der Merwe, and S. N. Abraham. 1999. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc. Natl. Acad. Sci. USA 96: 8110-8115.
56. Shin, J. S., Z. Gao, and S. N. Abraham. 2000. Involvement of cellular caveolae in bacterial entry into mast cells. Science 289: 785-788.